Details
Stereochemistry | ACHIRAL |
Molecular Formula | C4H4N2 |
Molecular Weight | 80.088 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C1=CN=CC=N1
InChI
InChIKey=KYQCOXFCLRTKLS-UHFFFAOYSA-N
InChI=1S/C4H4N2/c1-2-6-4-3-5-1/h1-4H
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
A diruthenum(III) complex possessing a diazine and two chloride bridges: synthesis, structure, and properties. | 2001 Aug 27 |
|
Hydrothermal syntheses, structures, and properties of [Cu3Cl2CN(pyrazine)] and copper(I) halide pyrazine polymers. | 2001 Jan 1 |
|
2:1 complexes of 2-chloro-4-nitrobenzoic acid and 2-chloro-5-nitrobenzoic acid with pyrazine. | 2001 Jul |
|
Dimetalation of pyrazines. a one-pot synthesis of multisubstituted pyrazine C-nucleosides. | 2001 Jul 13 |
|
Poly[copper(II)-mu-pyrazine-mu(3)-squarato]. | 2001 Mar |
|
Photoelectron imaging on time-dependent molecular alignment created by a femtosecond laser pulse. | 2001 May 14 |
|
Cu4(CH3C(OH)(PO3)2)2(C4H4N2)(H2O)4: a novel, three-dimensional copper diphosphonate with metamagnetism. | 2001 Nov 21 |
|
The FEMA GRAS assessment of pyrazine derivatives used as flavor ingredients. Flavor and Extract Manufacturers Association. | 2002 Apr |
|
Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity. | 2002 Dec |
|
Synthesis and biological activity of 5-alkyl-6-(alkylsulfanyl)- or 5-alkyl-6-(arylsulfanyl)pyrazine-2-carboxamides and corresponding thioamides. | 2002 Jan |
|
Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165. | 2002 Jul 18 |
|
Volatile compounds of headspace gas in the Japanese fish sauce ishiru. | 2002 Oct |
|
From linear inorganic chains to helices: chirality in the M(pyz)(H(2)O)(2)MoO(2)F(4) (M = Zn, Cd) compounds. | 2002 Sep 23 |
|
Spontaneously organizing metal connectors as supramolecular structure directors of two- and three-dimensional organometallic assemblies. | 2003 Apr 14 |
|
Silver(I) coordination chemistry of 2,6-diarylpyrazines. Pi-stacking, anion coordination, and steric control. | 2003 Aug 25 |
|
In situ co-crystallisation as a tool for low-temperature crystal engineering. | 2003 Jan 21 |
|
Mechanisms responsible for the in vitro relaxation of ligustrazine on porcine left anterior descending coronary artery. | 2003 May 16 |
|
Effects of heterocyclic aromatic substituents on binding affinities at two distinct sites of somatostatin receptors. Correlation with the electrostatic potential of the substituents. | 2003 May 8 |
|
Dinuclear versus mononuclear ruthenium(II) and osmium(II) complexes as potent mediators of glucose oxidase; crystal structure of [OsCl(4,4'-bpy)(bpy)2]BF4. | 2003 Nov |
|
Synthesis and pharmacological evaluation of (Z)-9-(heteroarylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes: thiophene analogues as potent norepinephrine transporter inhibitors. | 2003 Oct 20 |
|
Total synthesis of (+/-)-alantrypinone by hetero Diels-Alder reaction. | 2004 Jan 9 |
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
JECFA EVALUATION |
PYRAZINE
Created by
admin on Fri Dec 15 17:19:40 GMT 2023 , Edited by admin on Fri Dec 15 17:19:40 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
300000045822
Created by
admin on Fri Dec 15 17:19:40 GMT 2023 , Edited by admin on Fri Dec 15 17:19:40 GMT 2023
|
PRIMARY | |||
|
9261
Created by
admin on Fri Dec 15 17:19:40 GMT 2023 , Edited by admin on Fri Dec 15 17:19:40 GMT 2023
|
PRIMARY | |||
|
400221
Created by
admin on Fri Dec 15 17:19:40 GMT 2023 , Edited by admin on Fri Dec 15 17:19:40 GMT 2023
|
PRIMARY | |||
|
206-027-6
Created by
admin on Fri Dec 15 17:19:40 GMT 2023 , Edited by admin on Fri Dec 15 17:19:40 GMT 2023
|
PRIMARY | |||
|
30953
Created by
admin on Fri Dec 15 17:19:40 GMT 2023 , Edited by admin on Fri Dec 15 17:19:40 GMT 2023
|
PRIMARY | |||
|
2JKE371789
Created by
admin on Fri Dec 15 17:19:40 GMT 2023 , Edited by admin on Fri Dec 15 17:19:40 GMT 2023
|
PRIMARY | |||
|
PYRAZINE
Created by
admin on Fri Dec 15 17:19:40 GMT 2023 , Edited by admin on Fri Dec 15 17:19:40 GMT 2023
|
PRIMARY | |||
|
m9338
Created by
admin on Fri Dec 15 17:19:40 GMT 2023 , Edited by admin on Fri Dec 15 17:19:40 GMT 2023
|
PRIMARY | Merck Index | ||
|
290-37-9
Created by
admin on Fri Dec 15 17:19:40 GMT 2023 , Edited by admin on Fri Dec 15 17:19:40 GMT 2023
|
PRIMARY | |||
|
DTXSID8049410
Created by
admin on Fri Dec 15 17:19:40 GMT 2023 , Edited by admin on Fri Dec 15 17:19:40 GMT 2023
|
PRIMARY | |||
|
728
Created by
admin on Fri Dec 15 17:19:40 GMT 2023 , Edited by admin on Fri Dec 15 17:19:40 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD